FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 310:737-743 March 22, 1984 Number 12 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

After curative surgical resection, 621 patients with modified Dukes' stage B2, C1, or C2 colon carcinoma were randomly assigned to one of four treatment programs. These included chemotherapy with fluorouracil and semustine, immunotherapy with methanol extraction residue of bacillus Calmette-Guerin (BCG), combination therapy with fluorouracil, semustine, and immunotherapy, or close follow-up without adjuvant treatment. Treatment continued for 70 weeks. After a median of 51/2 years of follow-up, no significant differences were noted in either recurrence or survival rates among the four treatment programs. Leukemia developed in seven patients, all of whom had received fluorouracil and semustine. The results of this study do not support the use of chemotherapy with fluorouracil and semustine, immunotherapy with methanol extraction residue of BCG, or their combination as an adjuvant treatment program for patients at high risk for recurrent colon carcinoma. The data do, however, demonstrate the necessity for an untreated control group in a trial of adjuvant therapy for colon cancer.

This article has been cited by other articles:

• Chua, Y. J., Sargent, D., Cunningham, D. (2005). Definition of disease-free survival: this is my truth-show me yours. Ann Oncol 16: 1719-1721 [Full Text]  
• Perrone, F., Gallo, C., Daniele, B., Nauta, R. J., Warren, J. L., Brown, M. L., Sargent, D. J., Goldberg, R. M., Jacobson, S. D. (2002). Chemotherapy in the Elderly. NEJM 346: 622-623 [Full Text]  
• Minsky, B. D. (1997). Adjuvant Therapy for Rectal Cancer -- A Good First Step. NEJM 336: 1016-1017 [Full Text]  
• Shibata, D., Reale, M. A., Lavin, P., Silverman, M., Fearon, E. R., Steele, G., Jessup, J. M., Loda, M., Summerhayes, I. C. (1996). The DCC Protein and Prognosis in Colorectal Cancer. NEJM 335: 1727-1732 [Abstract] [Full Text]  
• Saltz, L. B., Kemeny, N. E. (1996). Adjuvant Chemotherapy of Colorectal Cancer. The Oncologist 1: 22-29 [Abstract] [Full Text]  
• Moertel, C. G. (1994). Chemotherapy for Colorectal Cancer. NEJM 330: 1136-1142 [Full Text]